Skip to content
10-Q

Quarterly Report

JINZANGHUANG TIBET PHARMACEUTICALS, INC.

0001096906-12-002739

← back to feed
Filed
Nov 13, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Nov 14, 2012 50.67M sh
Operating Cash Flow Q1 2013 · Sep 30, 2012 $1.74M
Operating Cash Flow Q1 2013 · Sep 30, 2011 $1.37M
Stockholders Equity Q1 2013 · Sep 30, 2012 $11.8M
Stockholders Equity Q1 2013 · Jun 30, 2012 $8.99M
Total Liabilities Q1 2013 · Sep 30, 2012 $798.49K
Total Liabilities Q1 2013 · Jun 30, 2012 $632.3K
Current Assets Q1 2013 · Sep 30, 2012 $12.58M
Current Assets Q1 2013 · Jun 30, 2012 $9.5M
Total Assets Q1 2013 · Sep 30, 2012 $13.16M
Total Assets Q1 2013 · Jun 30, 2012 $10.09M
Sga Expense Q1 2013 · Sep 30, 2012 $70.66K
Sga Expense Q1 2013 · Sep 30, 2011 $114.64K
Net Income Q1 2013 · Sep 30, 2012 $1.83M
Net Income Q1 2013 · Sep 30, 2011 $1.53M
Operating Income Q1 2013 · Sep 30, 2012 $2.56M
Operating Income Q1 2013 · Sep 30, 2011 $2.09M
Gross Profit Q1 2013 · Sep 30, 2012 $2.63M
Gross Profit Q1 2013 · Sep 30, 2011 $2.2M
Cost Of Revenue Q1 2013 · Sep 30, 2012 $700.67K
Cost Of Revenue Q1 2013 · Sep 30, 2011 $363.14K
Revenue Q1 2013 · Sep 30, 2012 $3.33M
Revenue Q1 2013 · Sep 30, 2011 $2.56M